A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.
Clinical trial NCT00677105 · COMPLETED
Trial details
- NCT number
- NCT00677105
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2011-09-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.